Article Text

Download PDFPDF
G124(P) Vitamin D deficiency in Neonates – An under recognised and under treated problem
  1. T Waterfield,
  2. C Checuti-Ganado
  1. NICU, Luton and Dunstable University Hospital, Luton, UK


Background Maternal Vitamin D deficiency has implications for neonatal health with increased rates of intrauterine growth restriction and metabolic bone disease.1 Screening for Vitamin D deficiency in pregnancy is not recommended and currently most antenatal units direct testing based on maternal risk factors.1,2 Treating Vitamin D deficiency in neonates is controversial with most guidelines suggesting a Vitamin D dose of 1000–2000IU for a period of 6–12 weeks; although it has been suggested that this may be insufficient2,3,4. As far as we are aware there are no RCTs exploring the appropriate dose and duration of Vitamin D supplementation in Vitamin D deficient term neonates.

We routinely treat Vitamin D deficient neonates with 3000IU of Cholecalciferol for 12 weeks; and as far as we are aware we are the first to present data on the safety and effectiveness of such a regimen.


  1. Assess our current approach to antenatal Vitamin D testing

  2. Determine the safety and effectiveness of 3000IU of Cholecaliferol over 12 weeks in term neonates.

Methods We conducted a prospective audit over 9 months; Vitamin D deficient mothers were identified by the obstetric team and neonates born to Vitamin D deficient mothers had their Vitamin D (25(OH)D) levels tested at birth using the Abbott Architect assay. Neonates with Vitamin D levels of <30nmol/l were treated for 12 weeks with 3000IU of Cholecalciferol.

Results Based on local demographic data and birth rates we would expect approximately 970 Vitamin D deficient (<25nmol/l)2 mothers to deliver during the study period – Only 17 expectant mothers (1.8%) were diagnosed as Vitamin D deficient.

Of those neonates treated with 3000 IU of Cholecalciferol for 3 months (n = 10), none reached toxic levels (>250nmol/l). Following treatment the Vitamin D level significantly increased (P = 0.002), with a median 25(OH)D level of 94nmol/l (IQR 75–94.5).

Conclusion Maternal Vitamin D deficiency is under recognised and screening of high risk groups should be considered in pregnancy. Our experience suggests 3000IU Cholecalciferol over 12 weeks is a safe and effective treatment for Vitamin D deficiency in neonates.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.